On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...
Latest Stories
Celebrating Dr. Soror Sharifpoor
After eight transformative years at the Ted Rogers Centre for Heart Research (TRCHR), Dr. Soror Sharifpoor is embarking on an exciting new chapter in her career. As the Director of Strategy & Translation at the Translational Biology and Engineering Program (TBEP)...
Our 2023-24 Innovation Fund Award Winners
With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
Welcome Iris Cohn, the Centre’s New Innovator in Genomic Translation
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Announced as Winner of ECHO PITCH 2024
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
New study illustrates a novel approach to uncovering genetic causes of congenital heart disease in the “dark genome” using AI
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
After a heart attack, this peptide protects the heart from further injury
Featured Event
ECHO PITCH 2024
Virtual Library
Visit our YouTube channel filled with world-class heart failure educational sessions on diverse topics
- This event has passed.
Medicine by Design: Grand Questions: Glimpse the future of Regenerative Medicine
May 7, 2021 @ 10:00 am - 11:00 am EDT
Last year, Medicine by Design challenged its researchers to think boldly about how they would solve regenerative medicine’s grand questions such as how to create tissues that outperform nature to resist novel infections or cancer or how to make regenerative medicine affordable and accessible to everyone. Now, we are investing $3 million in some of their most ambitious ideas with the ultimate goal of preparing the foundation for the future of human health.
Please see the agenda of the event, below:
At the event
- 10 a.m. – Greetings from Christine Allen
Associate Vice-President and Vice-Provost, Strategic Initiatives, University of Toronto and Professor, Leslie Dan Faculty of Pharmacy - 10:05 a.m. – Announcement of Grand Questions funded projects
Meet the extraordinary Grand Questions teams that will help make regenerative medicine solutions a reality for all disease. - 10:10 a.m. – Panel discussion
“Ambitious and provocative – expanding the frontiers of Regenerative Medicine”
Moderated by Janet Rossant, President and Scientific Director, The Gairdner Foundation and Chief of Research Emeritus, SickKids Research Institute.
This interactive panel discussion will focus on why ambitious, provocative and non-obvious solutions are the future of regenerative medicine.
For registration details, please visit https://www.eventbrite.ca/e/grand-questions-glimpse-the-future-of-regenerative-medicine-tickets-151397462887.